$39.23
0.93% yesterday
Nasdaq, Nov 07, 10:00 pm CET
ISIN
US04280A1007
Symbol
ARWR

Arrowhead Pharmaceuticals, Inc. Stock price

$39.23
+2.69 7.36% 1M
+26.17 200.38% 6M
+20.43 108.67% YTD
+17.84 83.40% 1Y
+4.92 14.34% 3Y
-28.87 42.39% 5Y
+33.81 623.80% 10Y
+4.23 12.09% 20Y
Nasdaq, Closing price Fri, Nov 07 2025
-0.37 0.93%

New AI Insights on Arrowhead Pharmaceuticals, Inc. Insights AI Insights on Arrowhead Pharmaceuticals, Inc.

How does the company make money?
Who are the company’s main competitors?

Key metrics

Basic
Market capitalization
$5.5b
Enterprise Value
$5.2b
Net debt
positive
Cash
$898.2m
Shares outstanding
138.1m
Valuation (TTM | estimate)
P/E
negative | 524.1
P/S
9.6 | 7.2
EV/Sales
9.0 | 6.8
EV/FCF
negative
P/B
10.5
Financial Health
Equity Ratio
16.3%
Return on Equity
-323.3%
ROCE
-9.1%
ROIC
-26.1%
Debt/Equity
1.1
Financials (TTM | estimate)
Revenue
$573.0m | $759.5m
EBITDA
$-85.4m | $82.8m
EBIT
$-108.0m | $59.1m
Net Income
$-148.4m | $10.4m
Free Cash Flow
$-17.6m
Growth (TTM | estimate)
Revenue
2,815.9% | 21,293.2%
EBITDA
83.9% | 114.2%
EBIT
80.3% | 109.8%
Net Income
72.4% | 101.7%
Free Cash Flow
96.7%
Margin (TTM | estimate)
Gross
-
EBITDA
-14.9% | 10.9%
EBIT
-18.8%
Net
-25.9% | 1.4%
Free Cash Flow
-3.1%
More
EPS
$-1.1
FCF per Share
$-0.1
Short interest
10.9%
Employees
609
Rev per Employee
$10.0k
Show more

Is Arrowhead Pharmaceuticals, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,024 stocks worldwide.

Arrowhead Pharmaceuticals, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a Arrowhead Pharmaceuticals, Inc. forecast:

15x Buy
75%
5x Hold
25%

Analyst Opinions

20 Analysts have issued a Arrowhead Pharmaceuticals, Inc. forecast:

Buy
75%
Hold
25%

Financial data from Arrowhead Pharmaceuticals, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
573 573
2,816% 2,816%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 123 123
14% 14%
21%
- Research and Development Expense 536 536
21% 21%
93%
-85 -85
84% 84%
-15%
- Depreciation and Amortization 23 23
29% 29%
4%
EBIT (Operating Income) EBIT -108 -108
80% 80%
-19%
Net Profit -148 -148
72% 72%
-26%

In millions USD.

Don't miss a Thing! We will send you all news about Arrowhead Pharmaceuticals, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Arrowhead Pharmaceuticals, Inc. Stock News

Neutral
Business Wire
one day ago
PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it will host a webcast and conference call on November 25, 2025, at 4:30 p.m. ET to discuss its financial results for the 2025 fiscal year ended September 30, 2025. Webcast and Conference Call Details Investors may access a live audio webcast on the Events and Presentations page unde...
Positive
The Motley Fool
3 days ago
Sold 138,263 shares of Arrowhead Pharmaceuticals; Estimated transaction value: $3,039,518 Post-trade stake: 473,951 shares valued at $16.35 million as of September 30, 2025 Arrowhead Pharmaceuticals now accounts for 2.94% of fund AUM, which places it outside the fund's top five holdings
Neutral
Business Wire
4 days ago
PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events: American Heart Association (AHA) Scientific Sessions 2025 – November 7-10, 2025 Title: Rationale and Design: Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of Zodasiran in Adolescents...
More Arrowhead Pharmaceuticals, Inc. News

Company Profile

Arrowhead Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops medicines that treat intractable diseases by silencing the genes that cause them. The company was founded by R. Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Head office United States
CEO Christopher Anzalone
Employees 609
Founded 1989
Website arrowheadpharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today